Miguel A. Rodriguez-Bigas, M.D., FACS, FASCRS
Department of Colon & Rectal Surgery, Division of Surgery
Present Title & Affiliation
Primary Appointment
Professor, Department of Colon & Rectal Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1982 | University of Puerto Rico School of Medicine, San Juan, PR, USA, MD, Medical Degree |
| 1978 | George Washington University, Washington, DC, USA, BS, Chemistry |
Postgraduate Training
| 1989-1990 | Surgical Oncology Fellowship, Roswell Park Cancer Institute, Buffalo, NY |
| 1988-1989 | Head & Neck Surgery Fellowship, Roswell Park Cancer Institute, Buffalo, NY |
| 1987-1988 | Surgical Oncology Fellowship, Roswell Park Cancer Institute, Buffalo, NY |
| 1983-1987 | General Surgery Resident, University of Puerto Rico, University Hospital, Department of Surgery, San Juan, PR |
| 1982-1983 | General Surgery Internship, University of Puerto Rico, University Hospital, Department of Surgery, San Juan, PR |
Board Certifications
| 2006 | American Board of Surgery |
| 1997 | American Board of Surgery |
| 1988 | American Board of Surgery |
| 1983 | National Board of Medical Examiners |
Experience & Service
Academic Appointments
Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2020
Associate Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1998 - 2001
Assistant Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1991 - 1998
Clinical Assistant Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1990 - 1991
Administrative Appointments/Responsibilities
Chief, Division of Colorectal Surgery, Department of Department of Surgery, Roswell Park Cancer Institute, Buffalo, NY, 2000 - 2001
Adjunct Faculty, Physician Assistant Program, D'Youville College, Buffalo, NY, 1994 - 2001
Director, Hereditary Nonpolyposis Colorectal Cancer Registry, Roswell Park Cancer Institute, Buffalo, NY, 1993 - 2001
Director, Familial Polyposis Registry, Roswell Park Cancer Institute, Buffalo, NY, 1990 - 2001
Institutional Committee Activities
Member, UT MD Anderson Cancer Center Professionalism Committee, 2016 - Present
Member, UT MD Anderson Cancer Center Bylaws Committee, 2016 - Present
Member, UT MD Anderson Cancer Center Executive Committee of the Medical Staff, 2014 - 2017
Member, The University of Texas M. D. Anderson Cancer Center, Faculty Senate, 2005 - 2008
Honors & Awards
| 2015 | Best Doctors in America |
| 2014 | Best Doctors in America |
| 2013 | Best Doctors in America |
| 2012 | Best Doctors in America |
| 2011 | Best Doctors in America |
| 2010 | Best Doctors in America |
| 2009 | Best Doctors in America |
| 2008 | Best Doctors in America |
| 2008 | America's Top Oncologists, Guide to America's Top Oncologists |
| 2008 | Castle Connolly Top Doctor, Castle Connolly Medical Ltd |
| 2007 | Best Doctors in America |
| 2006 | Best Doctors in America |
| 2005 | Outstanding Teacher Award, University of Texas M. D. Anderson Cancer Center |
| 2005 | Best Doctors in America |
| 1999 | Golden Apple Teaching Award, Best Teacher of the Year, Roswell Park Cancer Institute |
| 1999 | Outstanding Patient Care Award, Roswell Park Cancer Institute |
| 1996 | Outstanding Young Men of America |
| 1996 | Ambassador, The Greater Buffalo Convention and Visitors Bureau |
| 1995 | "40 Under Forty" Honor Roll, Buffalo's Business First, Western New York's Business Newspaper |
| 1992 | Citation's Who's Who Among Rising Young Americans in American Society and Business |
| 1989 | Clinical Oncology Fellowship, The American Cancer Society |
| 1988 | Third Prize; Annual Residents and Fellows Essay Contest, Western New York Chapter of The American College of Surgeons |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Coletta AM, Peterson SK, Gatus LA, Krause KJ, Schembre SM, Gilchrist SC, Arun B, You YN, Rodriguez-Bigas MA, Strong LL, Lu KH, Basen-Engquist K. Diet, weight management, physical activity and Ovarian & Breast Cancer Risk in women with BRCA1/2 pathogenic Germline gene variants: systematic review. Hered Cancer Clin Pract 18:5, 2020. PMID: 32165993.
- Donato KM, Moore K, Parker WM, Peterson SK, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, You YN, Burton-Chase AM. Health and lifestyle behaviors in colorectal cancer survivors with and without Lynch syndrome. J Community Genet 11(1):59-63, 2020. e-Pub 2019. PMID: 31016603.
- Eng C, Jácome AA, Das P, Chang GJ, Rodriguez-Bigas M, Skibber JM, Wolff RA, Qiao W, Xing Y, Sethi S, Ohinata A, Crane CH. A phase II study of capecitabine/oxaliplatin with concurrent radiotherapy in locally advanced squamous cell carcinoma of the anal canal. Clin Colorectal Cancer 18(4):301-306, 2019. PMID: 31350201.
- Coletta AM, Peterson SK, Gatus LA, Krause KJ, Schembre SM, Gilchrist SC, Pande M, Vilar E, You YN, Rodriguez-Bigas MA, Strong LL, Lynch PM, Lu KH, Basen-Engquist K. Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review. Fam Cancer 18(4):399-420, 2019. e-Pub 2019. PMID: 31236808.
- Malakorn S, Yang Y, Bednarski BK, Kaur H, You YN, Holliday EB, Dasari A, Skibber JM, Rodriguez-Bigas MA, Chang GJ.. Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation?. Dis Colon Rectum 62(10):1158-1166, 2019. PMID: 31490825.
- Mork ME, Rodriguez A, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Thirumurthi S, You YN, Vilar E. Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer. Cancer Genet 235-236:77-83, 2019. PMID: 31101557.
- Jiang W, Cai M, Li S, Bei J, Wang F, Hampel H, Ling Y, Frayling IM, Sinicrope FA, Rodriguez-Bigas MA, Dignam JJ, Kerr DJ, Rosell R, Mao M, Li J, Guo Y, Wu X, Kong L, Tang J, Wu X, Li C, Chen J, Ou Q, Ye M, Guo F, Han P, Wang Q, Wan D, Li L, Xu R, Pan Z, Ding P. Universal screening for Lynch Syndrome in a large consecutive cohort of Chinese colorectal cancer patients: high prevalence and unique molecular features. Int J Cancer 144(9):2161-2168, 2019. PMID: 30521064.
- You YN, Borras E, Chang K, Price BA, Mork M, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Meric-Bernstam F, Vilar E. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum 62(4):429-437, 2019. PMID: 30730459.
- Cloyd JM, Chun YS, Ikoma N, Vauthey JN, Aloia TA, Cuddy A, Rodriguez-Bigas MA, Nancy You Y. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome. J Gastrointest Cancer 49(1):93-96, 2018. PMID: 29238914.
- Ali SM, Pawlik TM, Rodriguez-Bigas MA, Monson JR, Chang GJ, Larson DW. Timing of surgical resection for curative colorectal cancer with liver metastasis. Ann Surg Oncol 25(1):32-37, 2018. e-Pub 2017. PMID: 28224365.
- Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF, Chang GJ. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum 1(1):77-83, 2018. PMID: 29215474.
- Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 8(6):990-997, 2017. PMID: 29299359.
- Borras E, Chang K, Pande M, Cuddy A, Bosch JL, Bannon SA, Mork ME, Rodriguez-Bigas MA, Taggart MW, Lynch PM, You YN, Vilar E. In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prev Res (Phila) 10(10):580-587, 2017. PMID: 28765196.
- Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of recurrence and salvage surgery on survival after multidisciplinary treatment of rectal cancer. J Clin Oncol 35(23):2631-2638, 2017. e-Pub 2017. PMID: 28657814.
- Mork ME, Rodriguez A, Taggart MW, Rodriguez-Bigas MA, Lynch PM, Bannon SA, You YN, Vilar E. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome. Fam Cancer 16(3):357-361, 2017. PMID: 28004223.
- Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ. Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer following neoadjuvant chemoradiation therapy. Am J Clin Oncol 40(3):277-282, 2017. PMID: 27028350.
- Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer 123(7):1124-1133, 2017. e-Pub 2016. PMID: 27479827.
- Sturgeon JD, Crane CH, Krishnan S, Minsky BD, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Eng C, Das P. Definitive chemoradiation for squamous cell carcinoma of the rectum. Am J Clin Oncol 40(2):163-166, 2017. PMID: 25222072.
- Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol 2(3):455-464, 2017. PMID: 29114614.
- Burton-Chase AM, Parker WM, Polivka KM, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, Nancy You Y, Peterson SK. A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers. Cancer Med 6(3):698-707, 2017.
- Messick CA, Rodriguez-Bigas MA. Anal Dysplasia. Surg Oncol Clin N Am 26(1):33-34, 2017. PMID: 27889035.
- Sammour T, Rodriguez-Bigas MA, Skibber JM. Locally Recurrent Disease Related to Anal Canal Cancers. Surg Oncol Clin N Am 26(1):115-125, 2017. PMID: 27889030.
- Carmack CL, Basen-Engquist K, Yuan Y, Greisinger A, Rodriguez-Bigas M, Wolff RA, Barker T, Baum G, Pennebaker JW. Feasibility of an expressive-disclosure group intervention for post-treatment colorectal cancer patients: Results of the healthy expressions study. Cancer 117(21):4993-5002, 2011. e-Pub 2011. PMID: 21480203.
- Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM, Das P. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117(16):3713-22, 2011. e-Pub 2011. PMID: 21328329.
- You YN, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM. Prognostic Value of Quality of Life and Pain in Patients with Locally Recurrent Rectal Cancer. Ann Surg Oncol 18(4):989-996, 2011. e-Pub 2010. PMID: 21132391.
- Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol 17(11):2863-9, 2010. e-Pub 2010. PMID: 20552409.
- Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?. J Am Coll Surg 210(6):934-41, 2010. PMID: 20510802.
- Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated Accelerated Radiotherapy for Rectal Cancer in Patients with Prior Pelvic Irradiation. Int J Radiat Oncol Biol Phys 77(1):60-5, 2010. e-Pub 2009. PMID: 19695792.
- Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 76(3):824-30, 2010. e-Pub 2009. PMID: 19464823.
- Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, Delclos ME, Feig BW. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol 17(2):441-7, 2010. e-Pub 2009. PMID: 19847569.
- Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg 251(2):261-4, 2010. PMID: 19864936.
- Jasperson KW, Vu TM, Schwab AL, Neklason DW, Rodriguez-Bigas MA, Burt RW, Weitzel JN. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer 9(2):99-107, 2010. e-Pub 2009. PMID: 19731080.
- De Jesus-Monge WE, Gonzalez-Keelan C, Zhao R, Hamilton SR, Rodriguez-Bigas M, Cruz-Correa M. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer 9(2):155-166, 2010. e-Pub 2009. PMID: 20012372.
Invited Articles
- Rodriguez-Bigas MA, Chang GJ, Skibber JM. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am 19(4):847-59, 2010. PMID: 20883958.
Abstracts
- You YN, Vilar E, Cuddy A, Wu A, Lynch PM, Eng C, Rodriguez-Bigas MA, Chang GJ. Are young adults with colorectal cancer doing enough to stay healthy?. AACR Annual Meeting 2015, 2015.
- Burton-Chase AM, Parker WM, Polivka KM, Gritz ER, Amos CI, Frazier ML, Lu KH, Lynch PM, Rodriguez-Bigas MA, You YN, Peterson SK. Provider satisfaction in colorectal cancer patients: A comparison between Lynch syndrome and sporadic survivors. CGA-ICC 18th Annual Meeting, 2014.
- Bailey CE, Rodriguez-Bigas MA, Tran Cao HA, Chang GJ, Feig B, Nguyen S, Skibber JM, You N. Persistent Functional Deficits and Symptoms among Long-Term Survivors of Colorectal Cancer Treated with Surgery and Multimodality Therapy: Differences by Age at Initial Diagnosis. Digestive Disease Week 2014, 2014.
- Morris VK, Rashis A, Rodriguez-Bigas MA, Das P, Wolff RA, Chang GJ, Crane CH, Phillips J, Ohinata A, Roger J, Eng C. Human papillomavirus is associated with unique clinicopathologic features in patients with metastatic squamous cell carcinoma of the anal canal. 2014 Gastrointestinal Cancers Symposium, 2014.
- Ernst R, Kaur H, Chang G, You YN, Rodriguez-Bigas M. Unraveling Colorectal Conference Conundrums using MRI. RSNA 2013, 2013.
- Sanchez EV, Wu W, Bhatia G, Cuddy A, Mork MM, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Taggart MW, You YN. Can microsatellite status of colorectal cancer (CRC) be reliably assessed after neoadjuvant therapy?. 2013 ASCO Annual Meeting, 2013.
- You NY, Bednarski B, Chang GJ, Khose S, Nguyen S, Feig B, Skibber J, Rodriguez-Bigas M. DNA Mismatch Repair Defects do not Account for the Majority of Newly Diagnosed Young-onset Colorectal Cancers. 2013 ASCRS Annual Meeting, 2013.
- You YN, Chang GJ, Cormier J, Fieg BW, Rodriguez-Bigas M, Skibber JM. A Framework For Developing Quality Measures Of Survivorship Care In Colorectal Cancer. 2013 Cancer Survivorship Research Retreat, 2013.
- You YN, Chang GJ, Feig BW, Skibber JM, Rodriguez-Bigas MA. DNA Mismatch Repair Defects Do Not Account for the Majority of Newly Diagnosed Young-Onset Colorectal Cancers. 2013 ASCRS Annual Meeting, 2013.
- You YN, Sanchez EV, Slack R, Chang GJ, Nguyen ST, Cuddy A, Khose S, Wisniewski W, Bannon S, Mork MM, Lynch PM, Rodriguez-Bigas M. Lynch syndrome testing in ethnically diverse patients: Mutation spectrum and performance of prediction models. 2013 ASCO Annual Meeting, 2013.
- Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggart MW, Skibber JM, Feig BW, You YN. Microsatellite high colorectal cancer: Does the underlying mechanism for instability matter?. 2012 Gastrointestinal Cancers Symposium, 2012.
- Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Maru D, Munsell MF, Celmons MV, Kopetz S, Garrett CR, Shureiqi I, Krishnan S, Delclos ME, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial. 2012 Gastrointestinal Cancers Symposium, 2012.
- Russell, M, Chiang Y, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind?. 2012 Gastrointestinal Cancers Symposium, 2012.
- Chang GJ, Hu CY, You YN, Eng C, Rodriguez-Bigas MA, Skibber JM. What determines adjuvant chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer?. 2012 Gastrointestinal Cancers Symposium, 2012.
- Mitchell MP, Abboud M, Crane CH, Eng C, Chang GJ, Rodriguez-Bigas MA, Skibber JM, You YN, Beddar S, Krishnan S, Delclos ME, Das P. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience. 2012 Gastrointestinal Cancers Symposium, 2012.
- Tzeng CD, Chang GJ, Curley SA, Vauthey JN, Ellis LM, Skibber JM, Feig BW, Abdalla EK, Aloia TA, You YN, Rodriguez-Bigas MA,. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis. 2012 Gastrointestinal Cancers Symposium, 2012.
- Park IJ, Eng C, You YN, Kopetz S, Rodriguez-Bigas MA, Overman MJ, Skibber JM, Chang GJ. Exploratory analysis of adjuvant chemotherapy effects after preoperative chemoradiotherapy and radical resection for rectal cancer. 2012 Gastrointestinal Cancers Symposium, 2012.
- Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-Caucasian patients. 2012 Gastrointestinal Cancers Symposium, 2012.
- Abbott DE, Cantor SB, Rodriguez-Bigas MA, Chang GJ, Lynch PM, Feig BW, Skibber JM, You YN. Detecting hereditary nonpolyposis colorectal cancer syndrome (HNPCC) in patients with colorectal cancer (CRC): Optimal strategies at lower costs. 2012 Gastrointestinal Cancers Symposium, 2012.
- Eng C, Rogrs J, Chang GJ, You YN, Das P, Rodriguez-Bigas MA, Ohinata A, Phillips J, Abbruzzese JL, Wolff RA. Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. 2012 ASCO Annual Meeting, 2012.
- Chang GJ, Park IJ, Eng C, You YN, Kopetz S, Overman MJ, Rodriguez-Bigas MA, Skibber JM. Exploratory analysis of adjuvant chemotherapy benefits after preoperative chemoradiotherapy and radical resection for rectal cancer. 2012 ASCO Annual Meeting, 2012.
- Tzeng CD, Chang GJ, Curley SA, Vauthey JN, Ellis LM, Skibber JM, Feig BW, Abdalla EK, Aloia TA, You YN, Rodriguez-Bigas MA. Morbidity of Staged Proctectomy after Hepatectomy for Colorectal Cancer: A Matched Case-control Analysis. Society of Surgical Oncology, 65th Annual Cancer Syposium, 2012.
- Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggart MW, Skibber JM, Feig BW, You YN,. Microsatellite High Colorectal Cancer: Does the Underlying Mechanism for Instability Matter?. Society of Surgical Oncology, 65th Cancer Symposium, 2012.
- Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Hereditary Nonpolyposis Colrectal Cancer in NonCaucasian Patients. Society of Surgical, 2012.
- Russell MC, Chian Y, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph Node Metastasis in Pateints with Early Pathologi T Stage Rectal Cancers: What Does Local Excision Leave Behind?. Society of Surgical Oncology, 65th Annual Cancer Symposium, 2012.
- You YN, Xing B, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ, Cormier JN. Advanced-stage colon cancer prior to the screening age: Association with age, race, and insurance status. 2011 Gastrointestinal Cancers Symposium, 2011.
- Eng C, Xing Y, You YN, Chang GJ, Das P, Phillips J, Wolff RA, Rodriguez-Bigas MA, Ohinata A, Crane CH. Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective. 2011 Gastrointestinal Cancers Symposium, 2011.
- Chagpar A, Cormier JN, Feig BW, Chang GJ, You YN, Rodriguez-Bigas MA, Skibber AM, Xing Y. Adherence to NCCN treatment guidelines for rectal cancer: Analysis of national practice patterns. 2011 ASCO Annual Meeting, 2011.
- Chang GJ, Park IJ, You YN, Hu C, Hamilton SR, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Nguyen ST, Rodriguez-Bigas MA, Skibber JM. Neoadjuvant treatment response and outcomes in locally advanced rectal cancer: Establishing oncologic benchmarks. 2011 ASCO Annual Meeting, 2011.
- Park IJ, Hu C, Rodriguez-Bigas MA, You YN, Skibber JM, Eng C, Wolff RA, Das P, Crane CH, Chang GJ. Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer. 2011 ASCO Annual Meeting, 2011.
- Patel CB, Kattepogu KM, Park IJ, Eng C, Delclos ME, Feig BW, Crane CH, Skibber JM, Das P, Rodriguez-Bigas MA, Krishnan S, Chang GJ. Impact of preoperative radiation dose escalation on pathologic outcomes and radiation toxicity in locally advanced rectal cancer (LARC): A matched-pair analysis. 2011 ASCO Annual Meeting, 2011.
- Abbott DE, Thomas AA, Rodriguez-Bigas MA, Skibber JM, Feig BW, You YN, Curley SA, Vauthey JN, Chang GJ. Economic Comparison of Simultaneous and Staged Resection for Synchronous Metastatic Colorectal Cancer. 97th Annual American College of Surgeons Clinical Congress, 2011.
- You YN, Halim H, Chang GJ, Rodriguez-Bigas MA. Prognostic value of pain and quality of life in patients with locally recurrent rectal cancer. Proc SSO, 2010.
- You YN, Saraiya D, Vu TM, Veerapong J, Lynch PM, Rodriguez-Bigas MA. Rectal cancer in patients with hereditary nonpolyposis colorectal cancer: surgical management and survival outcomes. 14th Annual Meeting of the Collaborative Group of the Americas on Colorectal Cancer, 2010.
- Ernst RD, Kaur H, You YN, Chang GJ, Rodriguez-Bigas MA. Structured reporting for MRI staging of rectal cancer. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2010.
- Saraiya D, You YN, Askew RL, Vu TM, Lynch PM, Rodriguez-Bigas MA. The importance of tumor studies in the initial evaluation for Lynch Syndrome: a coparison of MMR postive and negative patients. 14th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer, 2010.
- Bowles TL, Hu C, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Cancers of the colon and rectum. Proc ASCO GI, 2010.
- You YN, Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Crane CH, Das P, Chang GJ. Multimodal salvage therapy for locally recurrent and re-recurrent rectal cancer. Proc ASCO, 2010.
- Chang G, Maru D, Afarwal A, Schlette E, Wolff R, Rodriguez-Bigas MA, You YN, Feig B, Kopetz S, Skibber J, Eng C. Histopathologic responses in primary tumors of patients with metastatic colorectal carcinoma after neoadjuvant systemic chemotherapy alone. ESMO Conference: 12th World Congress on Gastrointestinal Cancer, 2010.
- Tsa CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BF, Eng C, Delclos M, Krishnan S, Das P. Number of lymph nodes retrieved and prognosis among pathologically node-negative patients after preoperative chemoradiation therapy for rectal cancer. Proc ASCO, 2010.
- Tanaka M, Bedrosian I, Chang GJ, You NY, Li D, Rodriguez-Bigas MA, Skibber JM, Abbruzzese JL, Eng C. Single nucleotide polymorphisms (SNPs) of hypoxia-related genes correlate with pathological complete response following neoadjuvant chemotherapy for locally advanced rectal cancer. Proc ASCO, 2010.
- Eng C, Sethi S, Chang G, Rodriguez-Bigas M, Skibber J, Shen J, Zhu J, Ohinata A, Hamilton S, Li D. Proteomic analysis of potential tumor markers in AJCC stage II and III colon cancer. Proc ASCO, 2009.
- Behm KT, Mathis KL, Shariq O, Bikhchandani J, Lynch H, Rodriguez-Bigas MA, Cuddy A, Dozois EJ, You Y. A Multi-institutional Study of Long-term Patient-reported Outcomes after Proctectomy vs. Proctocolectomy for Rectal Cancer in Patients with Lynch Syndrome. ASCRS 2016 Annual Scientific Meeting, Los Angeles, CA, April 30-May 4, 2016.
Book Chapters
- Orr WS, Pisters LL, Rodriguez-Bigas MA. Intraoperative Ureteral Injury. In: Gastrointestinal Surgery: Management of Complex Perioperative Complications. Springer: New York, 361-70, 2015.
- Bannon S, Mork M, Rodriguez-Bigas MA. The young patient with colorectal cancer-genetic counseling discussion. In: Colorectal Cancer: Diagnosis and Management. Wiley Blackwell, 275-285, 2014.
- Rodriguez-Bigas MA. Tratamiento de las metástasis hepáticas sincrónicas. In: Enfoque Multidisciplinario del Cáncer Colorectal. Ediciones Journal S.A: Argentina, 163-170, 2014.
- Roses RE, Rodriguez-Bigas MA. The Management of Rectal Cancer. In: Current Surgical Therapy. 11th. Elsevier Saunders: Philadelphia, PA, 218-224, 2013.
- Tan CH, Das P, Silberfein EJ, Rodriguez-Bigas MA, Iyer RB. Colorectal Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. 2nd. Elsevier Saunders: Philadelphia, PA, 267-286, 2012.
- Bhadkamkar N, Crane CH, Rodriguez-Bigas MA, Kopetz S, Eng C. Colorectal Cancer. In: The MD Anderson Manual of Medical Oncology. 2nd. McGraw-Hill: New York, 549-588, 2011.
- Rodriguez-Bigas, MA. Polipose associada ao MYH (PAM). In: Polipose Adenomatosa Familiar. Yendis: Sao Paulo, Brazil, 2010.
- Alberts AR, Citrin D, Rodriguez-Bigas MA, Das P. Colon, Rectal, and anal cancers. In: Cancer Management: A Multidisciplinary Approach. CMP Media, 2010.
- Rodriguez-Bigas MA. Genotype phenotype correlation in familial adenomatous polyposis. In: Hereditary Colorectal Cancer. Springer: New York, 197-202, 2010.
- Cutait R, Rodriguez-Bigas MA. Surgical management in Lynch Syndrome. In: Hereditary Colorectal Cancer. Springer: New York, 301-310, 2010.
Books (edited and written)
- Rodriguez-Bigas MA, Cutait R, Lynch PM, Tomlinson I, Vasen HFA. Hereditary Colorectal Cancer. In: M. D. Anderson Solid Tumor Oncology Series. Springer: New York, 2010.